Diabetes Mellitus Standards Flashcards
7 cards from real NRCME practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Diabetes Mellitus Standards flashcards as text
A commercial driver with diabetes is found to have microalbuminuria. This is most relevant to the examiner because it indicates:
Answer: Early diabetic kidney disease and elevated cardiovascular risk
Microalbuminuria signals early nephropathy and is a marker of systemic vascular disease that elevates overall cardiovascular risk.
When a driver with diabetes reports using a continuous glucose monitor (CGM), the examiner should understand that:
Answer: CGM is a monitoring tool and does not change FMCSA qualification requirements
CGM is a useful monitoring device but does not alter the legal qualification framework; drivers must still meet all FMCSA standards.
A driver with diabetes reports blurred vision that resolves after glucose correction. This symptom is medically significant because it suggests:
Answer: Episodic hypoglycemia or hyperglycemia causing transient visual changes that impair driving
Transient vision changes tied to glucose fluctuation indicate glycemic instability that can impair driving safely.
What is the primary reason FMCSA originally prohibited insulin-treated drivers from interstate commerce?
Answer: Risk of hypoglycemia causing sudden incapacitation while driving
The original prohibition was based on the risk that hypoglycemia could cause sudden loss of cognitive function or consciousness at the wheel.
A driver with Type 2 diabetes switches from metformin to a GLP-1 receptor agonist. From an FMCSA standpoint, the primary consideration is:
Answer: GLP-1 agents have low hypoglycemia risk and generally do not change certification status
GLP-1 receptor agonists have a very low hypoglycemia risk when used without insulin, so they typically do not trigger additional FMCSA restrictions.
Which scenario would most likely result in the examiner issuing a shorter than standard certification period for a diabetic CMV driver?
Answer: Recent medication change requiring stability confirmation
A recent medication change warrants a shorter certificate to verify glycemic stability and absence of adverse effects before full-period certification.
A driver with diabetes presents with a foot ulcer that is healing but not infected. The examiner's main concern regarding CMV safety is:
Answer: Whether peripheral neuropathy or vascular insufficiency compromising foot function affects pedal control
Foot ulcers often indicate peripheral neuropathy or vascular disease that may impair the driver's ability to reliably use foot pedals.